OPKO Health (NASDAQ: OPK) saw its stock price plummet 5.80% in after-hours trading on Wednesday following the release of its disappointing first-quarter 2025 financial results. The healthcare company's earnings and revenue figures fell short of analyst expectations, raising concerns about its performance.
OPKO Health reported a quarterly loss of $(0.10) per share, missing the analyst consensus estimate of $(0.07) by 42.86%. While this represents a slight improvement from the $(0.12) per share loss in the same period last year, the wider-than-expected loss likely contributed to the stock's decline. The company's revenue also disappointed, coming in at $149.90 million, which fell short of the analyst consensus estimate of $164.26 million by 8.74%. This marks a significant 13.70% decrease compared to the $173.70 million in sales reported for the same period last year.
The company's financial struggles were further highlighted by its reported net income of $(67.6) million for the quarter. OPKO Health's revenue from services, which stood at $102.8 million, suggests that the company is facing challenges in its core business operations. As investors digest these results, the after-hours stock plunge reflects growing concerns about OPKO Health's financial health and future prospects in the competitive healthcare sector.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.